Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human bladder cancer

Japanese Journal of Cancer Research

Volumn 90, Issue 12, 1999, Pages 1344-1350

  Tanaka, Tsutomu ^a   Yoshiki, Tatsuhiro ^a   Arai, Yoichi ^b   Higuchi, Kayoko ^c   Kageyama, Susumu ^a   Ogawa, Yasutaka ^d   Isono, Takahiro ^a   Okada, Yusaku ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b KURASHIKI CENTRAL HOSPITAL   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

^d NATL INSTITUTE OF INDUSTRIAL HEALTH   (Japan)

Author keywords

Bladder transitional cell carcinoma; Platelet derived endothelial cell growth factor; Thymidine phosphorylase

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; THYMIDINE PHOSPHORYLASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER MUCOSA; BLOOD LEVEL; CANCER INVASION; CANCER SURVIVAL; CLINICAL FEATURE; CYSTECTOMY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; ONCOGENE C ERB; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSITIONAL CELL CARCINOMA;

EID: 0033391689     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1999.tb00718.x     Document Type: Article

References (18)

1. Dickinson, A. J., Fox, S. B., Persad, R., Hollyer, J., Sibley, G. and Harris, A. Quantitation of angiogenesis is an independent predictor of prognosis in invasive bladder cancer. Br. J. Urol., 74, 762-766 (1994).
2. Ishikawa, F., Miyazono, K., Hellman, U., Drexler, H., Wernstedt, C., Hagiwara, K., Usuki, K., Takaku, F., Risau, W. and Heldin, C.-H. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature, 338, 557-562 (1989).
3. Furukawa, T., Yoshimura, A., Sumizawa, T., Haraguchi, M. and Akiyama, S. Angiogenic factor. Nature, 356, 668 (1992).
4. Yoshimura, A., Kuwazuru, Y., Furukawa, T., Yoshida, H., Yamada, K. and Akiyama, S. Purification and tissue distribution of human thymidine phosphorylase: high expression in lymphocytes, reticulocytes and tumors. Biochim. Biophys. Acta, 1034, 107-113 (1990).
5. Kubota, Y., Miura, T., Moriyama, M., Noguchi, S., Matuzaki, J., Takebayashi, S. and Hosaka, M. Thymidine phosphorylase activity in human bladder cancer. Clin. Cancer Res., 3, 973-976 (1997).
6. O'Brien, T. S., Cranston, D., Fuggle, S., Bicknell, R. and Harris, A. L. Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res., 55, 510-513 (1995).
7. O'Brien, T. S., Fox, S. B., Dickinson, A. J., Turley, H., Westwood, M., Moghaddam, A., Gatter, K. C., Bicknell, R. and Harris, A. L. Expression of the angiogenic factor thymidine phosphorylase/platelet-derived endothelial cell growth factor in primary bladder cancers. Cancer Res., 56, 4799-4804 (1996).
8. Sawase, K., Nomata, K., Kanetake, H. and Saito, Y. The expression of platelet-derived endothelial cell growth factor in human bladder cancer. Cancer Lett., 130, 35-41 (1988).
9. Isono, T., Isegawa, Y. and Seto, A. Sequence and diversity of variable gene segments coding for rabbit T-cell receptor beta chains. Immunogenetics, 39, 243-248 (1994).
10. Nishida, M., Hino, A., Mori, K., Matsumoto, T., Yoshikubo, T. and Ishituka, H. Preparation of anti-human thymidine phosphorylase monoclonal antibodies useful for detecting the enzyme levels in tumor tissues. Biol. Pharm. Bull., 19, 1407-1411 (1996).
11. Hamaguchi, A., Toyama, I., Yoshiki, T. and Kimura, H. Demonstration of fibroblast growth factor receptor-1 in human prostate as revealed by polymerase chain reaction and immunohistochemistry. Prostate, 27, 141-147 (1995).
12. Kokuho, M., Yoshiki, T., Okada, Y., Tomoyoshi, T. and Higuchi, K. Immunohistochemical study of c-erbB-2 protooncogene product in prostatic cancer. Jpn. J. Urol., 84, 1872-1878 (1993) (in Japanese).
13. Moriyama, M., Akiyama, T., Yamamoto, T., Kawamoto, T., Kato, T., Sato, K., Watanuki, T., Hikage, T., Katsuta, N. and Mori, S. Expression of c-erbB-2 gene product in urinary bladder cancer. J. Urol. 145, 423-427 (1991).
14. Imazano, Y., Takebayashi, Y., Nishiyama, K., Akiba, S., Miyadera, K., Yamada, Y., Akiyama, S. and Ohi, Y. Correlation between thymidine phosphorylase expression and prognosis in human renal cell carcinoma. J. Clin. Oncol., 15, 2570-2578 (1997).
15. Fujimoto, J., Ichigo, S., Sakaguchi, H., Hirose, R. and Tamaya, T. Expression of platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA in ovarian cancers. Cancer Lett., 126, 83-88 (1998).
16. Sawada, N., Ishikawa T., Fukase, Y., Nishida, M., Yoshikubo, T. and Ishitsuka, H. Induction of thymidine phosphorylase activity and enhancement of capecitabin efficacy by Taxol/Taxotere in human cancer xenografts. Clin. Cancer Res., 4, 1013-1019 (1998).
17. Sander, B., Damm, O., Gustafsson, B., Andersson, U. and Hakansson, L. Localization of IL-1, IL-2, IL-4, IL-8 and TNF in superficial bladder tumors treated with intravesical bacillus Calmette Guerin. J. Urol., 156, 536-541 (1996).
18. Pauly, J. L., Schuller, M. G., Zelcer, A. A., Kirss, T. A., Gore, S. S. and Germain, M. J. Identification and comparative analysis of thymidine phosphorylase in the plasma of healthy subjects and cancer patients. J. Natl. Cancer Inst., 58, 1587-1590 (1977).